Sergei is a medical physicist specializing in MRI technology and the investor behind Wellumio's pulsed gradient-free mapping (PGFM) technology. Before co-founding Wellumio, he developed imaging systems at the Robinson Research Institute and co-founded Resonint, bringing educational MRI systems to market in the U.S. He trained at McMaster University, where he worked on MRI coil development for Sentinel Medical, and completed industry fellowships at Tornado Medical. Sergei has collaborated with leaders in medical imaging, including Magritek and Synaptive Medical, and is deeply involved in the advancement of low-field MRI solutions for stroke care.

Gyan is a business executive with a background in scaling medtech and software ventures. Before Wellumio, he co-founded SmarMinds, an IT consulting firm supporting ASX-listed medical device companies, and later founded Facilitracks, a smart facilities management platform with enterprise clients like Marina Bay Sands and Auckland District Health Board. He previously served as VP of Product Operations at Philia Labs, a wearable biometrics startup, later becoming CEO and leading its funding round with investor across Australia and Singapore. Gyan brings operational expertise across Australia, Asia, Europe, and the US., helping drive Wellumio's global strategy.

Ziad is a MedTech industry leader with over 25 years of experience in product development, regulatory strategy, and commercialization. Before joining Wellumio, he was CEO of Biomodex, leading the company's global expansion and its acquisition by Mentice. He has held senior leadership roles at JUUL Labs, PQ Bypass (acquired by Endologix), Altura Medical (acquired by Lombard Medical), and Avinger (NASDAQ: AVGR). He has also worked in strategic roles at Guidant, Evalve (acquired by Abbott), and Codman (J&J). Ziad brings deep expertise in scaling MedTech ventures and guiding companies through regulatory and commercial milestones.

Harry has over 20 years of experience in finance, healthcare, medical technology, pharmaceuticals, and global leadership. He began his career in finance and accounting roles supporting multinational and regional businesses, building expertise in financial strategy, governance, and scale-up. He later joined Telix Pharmaceuticals, where he helped drive growth from an early-stage organisation to a globally commercialised biotech business. As Group Finance Director and APAC CFO, he led finance transformation, capital planning, and global expansion, supporting diagnostic launches across ANZ, USA, Europe, and Japan. More recently, he served as Group CFO at Simba Global, improving margins, governance, and international growth strategy. At Wellumio, Harry provides strategic finance leadership for commercialisation, capital formation, and scale-up.

David has over 20 years of experience in technology, product development, engineering, and regulated product commercialisation. He has deep expertise taking complex products from concept through to market, with hands-on leadership across architecture, compliance, security, and go-to-market execution. Most recently, he served as CTO at HitIQ, where he led product development, research, engineering, compliance, and commercial execution while owning architecture. He implemented ISO 13485 and ISO 27001-certified systems, helping teams move faster and safely. Previously, he held senior roles at dorsaVi across CTO, engineering, program leadership, and CISO responsibilities. He also led programs at Hydrix and worked on embedded SoC architecture at AMD. At Wellumio, David supports commercial milestones through product development and technology scale-up.

Sia has over 30 years of experience in health technology development and global senior leadership roles. He was the global leader for Technology Management Services at GE Healthcare in Chicago and previously served as President & CEO for GE Healthcare Asia Pacific in Korea, driving growth through business transformation and partnerships with Samsung Biologics and Celltrion. At GE, he led initiatives in customer experience, change management, and commercial transformation. He also headed GE’s clinical software and enterprise solutions for global growth markets. His expertise spans operational due diligence, M&A integration, and market expansion. Currently a senior advisor on entrepreneurial value creation, Sia also serves as Vice-Chair of the Institute of Personalized Therapeutic Nutrition. He holds engineering and business degrees from UBC.